Press Releases

May 12, 2026	PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights
Apr 22, 2026	PMV Pharmaceuticals Announces Board Chair Transition
Mar 06, 2026	PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Feb 26, 2026	New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors